| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.48 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 0.07 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |